RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates

被引：22

作者：

Pan, Xiaoyan ^{[1
,2
,3
]}

Shi, Jian ^{[4
]}

Hu, Xue ^{[1
,3
]}

Wu, Yan ^{[1
]}

Zeng, Liang ^{[4
]}

Yao, Yanfeng ^{[3
]}

Shang, Weijuan ^{[1
]}

Liu, Kunpeng ^{[1
,2
]}

Gao, Ge ^{[3
]}

Guo, Weiwei ^{[1
,2
]}

Peng, Yun ^{[3
]}

Chen, Shaohong ^{[1
]}

Gao, Xiaoxiao ^{[3
]}

Peng, Cheng ^{[3
]}

Rao, Juhong ^{[1
,2
]}

Zhao, Jiaxuan ^{[1
,2
]}

Gong, Cheng ^{[4
]}

Zhou, Hui ^{[4
]}

Lu, Yudong ^{[4
]}

Wang, Zili ^{[4
]}

Hu, Xiliang ^{[4
]}

Cong, WenJuan ^{[4
]}

Fang, Lijuan ^{[4
]}

Yan, Yongxiang ^{[4
]}

Zhang, Jing ^{[4
]}

Xiong, Hui ^{[4
]}

Yi, Jizu ^{[4
]}

Yuan, Zhiming ^{[1
,2
,3
]}

Zhou, Pengfei ^{[4
]}

Shan, Chao ^{[1
,2
,3
]}

Xiao, Gengfu ^{[1
,2
,3
]}

机构：

[1] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China

[2] Univ Chinese Acad Sci, Beijing, Peoples R China

[3] Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, Wuhan, Hubei, Peoples R China

[4] Wuhan YZY Biopharma Co Ltd, Wuhan, Hubei, Peoples R China

来源：

CELL DISCOVERY | 2021年 / 7卷 / 01期

基金：

国家重点研发计划;

关键词：

SARS-COV-2;

D O I：

10.1038/s41421-021-00320-y

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The pandemic of COVID-19 caused by SARS-CoV-2 has raised a new challenges to the scientific and industrious fields after over 1-year spread across different countries. The ultimate approach to end the pandemic is the timely application of vaccines to achieve herd immunity. Here, a novel SARS-CoV-2 receptor-binding domain (RBD) homodimer was developed as a SARS-CoV-2 vaccine candidate. Formulated with aluminum adjuvant, RBD dimer elicited strong immune response in both rodents and non-human primates, and protected mice from SARS-CoV-2 challenge with significantly reducing viral load and alleviating pathological injury in the lung. In the non-human primates, the vaccine could prevent majority of the animals from SARS-CoV-2 infection in the respiratory tract and reduce lung damage. In addition, antibodies elicited by this vaccine candidate showed cross-neutralization activities to SARS-CoV-2 variants. Furthermore, with our expression system, we provided a high-yield RBD homodimer vaccine without additional biosafety or special transport device supports. Thus, it may serve as a safe, effective, and low-cost SARS-CoV-2 vaccine candidate.

引用

页数：15

共 49 条

[1] Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, Lindsey R.
El Sahly, Hana M.
Essink, Brandon
Kotloff, Karen
Frey, Sharon
Novak, Rick
Diemert, David
Spector, Stephen A.
Rouphael, Nadine
Creech, C. Buddy
McGettigan, John
Khetan, Shishir
Segall, Nathan
Solis, Joel
Brosz, Adam
Fierro, Carlos
Schwartz, Howard
Neuzil, Kathleen
Corey, Larry
Gilbert, Peter
Janes, Holly
Follmann, Dean
Marovich, Mary
Mascola, John
Polakowski, Laura
Ledgerwood, Julie
Graham, Barney S.
Bennett, Hamilton
Pajon, Rolando
Knightly, Conor
Leav, Brett
Deng, Weiping
Zhou, Honghong
Han, Shu
Ivarsson, Melanie
Miller, Jacqueline
Zaks, Tal
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) : 403 - 416
[2] Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Chen, Rita E.
Zhang, Xianwen
Case, James Brett
Winkler, Emma S.
Liu, Yang
VanBlargan, Laura A.
Liu, Jianying
Errico, John M.
Xie, Xuping
Suryadevara, Naveenchandra
Gilchuk, Pavlo
Zost, Seth J.
Tahan, Stephen
Droit, Lindsay
Turner, Jackson S.
Kim, Wooseob
Schmitz, Aaron J.
Thapa, Mahima
Wang, David
Boon, Adrianus C. M.
Presti, Rachel M.
O'Halloran, Jane A.
Kim, Alfred H. J.
Deepak, Parakkal
Pinto, Dora
Fremont, Daved H.
Crowe, James E., Jr.
Corti, Davide
Virgin, Herbert W.
Ellebedy, Ali H.
Shi, Pei-Yong
Diamond, Michael S.
[J]. NATURE MEDICINE, 2021, 27 (04) : 717 - 726
[3] Viral targets for vaccines against COVID-19
Dai, Lianpan
Gao, George F.
[J]. NATURE REVIEWS IMMUNOLOGY, 2021, 21 (02) : 73 - 82
[4] A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
Dai, Lianpan
Zheng, Tianyi
Xu, Kun
Han, Yuxuan
Xu, Lili
Huang, Enqi
An, Yaling
Cheng, Yingjie
Li, Shihua
Liu, Mei
Yang, Mi
Li, Yan
Cheng, Huijun
Yuan, Yuan
Zhang, Wei
Ke, Changwen
Wong, Gary
Qi, Jianxun
Qin, Chuan
Yan, Jinghua
Gao, George F.
[J]. CELL, 2020, 182 (03) : 722 - +
[5] NEWS Alpha, Beta, Delta, Gamma: What's important to know about SARS-CoV-2 variants of concern?
Duong, Diana
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (27) : E1059 - E1060
[6] Ella R, 2021, LANCET INFECT DIS, V21, P637, DOI [10.1016/S1473-3099(20)30942-7, 10.1016/S1473-3099(21)00070-0]
[7] T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Ewer, Katie J.
Barrett, Jordan R.
Belij-Rammerstorfer, Sandra
Sharpe, Hannah
Makinson, Rebecca
Morter, Richard
Flaxman, Amy
Wright, Daniel
Bellamy, Duncan
Bittaye, Mustapha
Dold, Christina
Provine, Nicholas M.
Aboagye, Jeremy
Fowler, Jamie
Silk, Sarah E.
Alderson, Jennifer
Aley, Parvinder K.
Angus, Brian
Berrie, Eleanor
Bibi, Sagida
Cicconi, Paola
Clutterbuck, Elizabeth A.
Chelysheva, Irina
Folegatti, Pedro M.
Fuskova, Michelle
Green, Catherine M.
Jenkin, Daniel
Kerridge, Simon
Lawrie, Alison
Minassian, Angela M.
Moore, Maria
Mujadidi, Yama
Plested, Emma
Poulton, Ian
Ramasamy, Maheshi N.
Robinson, Hannah
Song, Rinn
Snape, Matthew D.
Tarrant, Richard
Voysey, Merryn
Watson, Marion E. E.
Douglas, Alexander D.
Hill, Adrian V. S.
Gilbert, Sarah C.
Pollard, Andrew J.
Lambe, Teresa
[J]. NATURE MEDICINE, 2021, 27 (02) : 270 - +
[8] Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.04.006, 10.1016/j.cell.2021.03.013, 10.1101/2021.02.14.21251704]
[9] D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction
Gobeil, Sophie M-C
Janowska, Katarzyna
McDowell, Shana
Mansouri, Katayoun
Parks, Robert
Manne, Kartik
Stalls, Victoria
Kopp, Megan F.
Henderson, Rory
Edwards, Robert J.
Haynes, Barton F.
Acharya, Priyamvada
[J]. CELL REPORTS, 2021, 34 (02):
[10] A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
Hassan, Ahmed O.
Kafai, Natasha M.
Dmitriev, Igor P.
Fox, Julie M.
Smith, Brittany K.
Harvey, Ian B.
Chen, Rita E.
Winkler, Emma S.
Wessel, Alex W.
Case, James Brett
Kashentseva, Elena
McCune, Broc T.
Bailey, Adam L.
Zhao, Haiyan
VanBlargan, Laura A.
Dai, Ya-Nan
Ma, Meisheng
Adams, Lucas J.
Shrihari, Swathi
Danis, Jonathan E.
Gralinski, Lisa E.
Hou, Yixuan J.
Schaefer, Alexandra
Kim, Arthur S.
Keeler, Shamus P.
Weiskopf, Daniela
Baric, Ralph S.
Holtzman, Michael J.
Fremont, Daved H.
Curiel, David T.
Diamond, Michael S.
[J]. CELL, 2020, 183 (01) : 169 - +

← 1 2 3 4 5 →